Bionano Genomics, Inc. (BNGO) Gross margin 2017–2025
Bionano Genomics, Inc. (BNGO) gross margin by fiscal year — reported gross profit divided by reported revenue.
46.3%FY2025 · since FY2017: 36.6% → 46.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 46.3% | +45.0 pp |
| FY2024 | 1.2% | -25.3 pp |
| FY2023 | 26.5% | +5.1 pp |
| FY2022 | 21.4% | -0.2 pp |
| FY2021 | 21.5% | -11.1 pp |
| FY2020 | 32.6% | -0.6 pp |
| FY2019 | 33.2% | +5.8 pp |
| FY2018 | 27.4% | -9.1 pp |
| FY2017 | 36.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice